60.7
Kyverna Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
291
FY25:
283
(positive)
Change from FY23 to FY25
millions USD
FY23:
14.5
FY24:
14.0
FY25:
10.9
Total assets
Change from FY23 to FY25
millions USD
FY23:
75.2
FY24:
305
FY25:
294
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
19.9
FY24:
33.8
FY25:
36.5
(negative)
Change from FY23 to FY25
millions USD
FY23:
6.16
FY24:
4.30
FY25:
25.1
(positive)
Change from FY23 to FY25
millions USD
FY23:
−131
FY24:
267
FY25:
232
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
305
FY25:
294
All amounts in millions USD